BIONTECH SE-ADR (BNTX:NASDAQ)
$92.45 1.36 (1.493%)
Analysed BIONTECH SE-ADR (BNTX:NASDAQ) News Sources
VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026
18-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
02-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
06-07-2026
yahoo.com
Former Pfizer Building Is Crumbling—Just as the Stock Has
07-07-2026
yahoo.com
Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
08-07-2026
yahoo.com
BioNTech (BNTX) Stock Could Be Overvalued After a 58% Five Year Slump
10-07-2026
yahoo.com
Is BioNTech (BNTX) Undervalued As It Exits German Manufacturing Sites?
10-07-2026
yahoo.com
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
21-07-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
24-07-2026
yahoo.com
2 Major Reasons to Buy Moderna Stock Before July 31
28-07-2026
247wallst.com
What is the current price of BIONTECH SE-ADR (BNTX:NASDAQ)?
The current price of BIONTECH SE-ADR (BNTX:NASDAQ) is $92.45.
BIONTECH SE-ADR (BNTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIONTECH SE-ADR (BNTX:NASDAQ) since the previous trading day is $1.36.
BIONTECH SE-ADR (BNTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIONTECH SE-ADR (BNTX:NASDAQ) since the previous trading day is 1.493%.
What is the most recent average sentiment score for BIONTECH SE-ADR (BNTX:NASDAQ)?
The most recent average sentiment score for BIONTECH SE-ADR (BNTX:NASDAQ) is 44 out of 100.
What is the most recent average sentiment for BIONTECH SE-ADR (BNTX:NASDAQ)?
The most recent sentiment for BIONTECH SE-ADR (BNTX:NASDAQ) is .
SEC-8K** Filing Available For BIONTECH SE-ADR (BNTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.